Insight
Liquid Biopsy Breakthrough – International Society of Liquid Biopsy
nature.com

Liquid Biopsy Breakthrough – International Society of Liquid Biopsy

International Society of Liquid Biopsy (ISLB) shared a post on X about a recent paper by James Black et al. published in Nature Medicine:

“Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma”

Authors: James Black, Gabor Bartha, Charles Abbott, Richard Chen, Charles Swanton et al.

“Liquid Biopsy Breakthrough.

New ultrasensitive ctDNA detection tools like NeXT Personal achieve unparalleled sensitivity (1–3 ppm). This can revolutionize early-stage NSCLC management by:

  • Pre-op disease stratification
  • Predicting worse clinical outcomes
  • Identifying ultra-low-risk patients

Study Highlights:

  • 81% detection in LUAD pre-op cases.
  • Significant OS impact: ctDNA presence = poorer survival.”

More posts International Society of Liquid Biopsy.

cancer Charles Abbott Charles Swanton ctDNA Gabor Bartha International Society of Liquid Biopsy ISLB James Black liquid biopsy lung adenocarcinoma OncoDaily Oncology Richard Chen